Table 1 Clinical and laboratory data of the study participants (n = 61)
Variable | No. (%) HIV/latent TB co-infected participants | ||
|---|---|---|---|
HAART-naïve n = 30 | HAART-treated n = 31 | Total n = 61 | |
CD4+ count (cells/μl), Median (IQR) | 445 (371–626) | 502 (363–564) | 477 (367–567) |
201–350 | 7 (23.3) | 4 (12.9) | 11 (18.0) |
351–500 | 10 (33.3) | 11 (35.5) | 21 (34.4) |
>500 | 13 (43.3) | 16 (51.6) | 29 (47.5) |
aHistory of Previous BCG Vaccination | |||
Yes | 2 (6.7) | 11 (35.5) | 13 (21.3) |
No | 28 (93.3) | 20 (64.5) | 48 (78.7) |
bRecent infections | |||
Present | 5 (16.7) | 1 (3.2) | 6 (9.8) |
Absent | 25 (83.3) | 30 (96.8) | 55 (90.2) |